Spots Global Cancer Trial Database for acetaminophen
Every month we try and update this database with for acetaminophen cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors | NCT02911961 | Acetaminophen E... | Acetaminophen | 21 Years - 80 Years | Denver Health and Hospital Authority | |
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers | NCT02648490 | Solid Tumour | HLX07 Acetaminophen dexamethasone diphenhydramine 5-HT3 inhibitor | 18 Years - | Henlix, Inc | |
Intravenous Acetaminophen for Craniotomy Patients | NCT01474304 | Craniotomy | Acetaminophen | 18 Years - | Swedish Medical Center | |
Usefulness of Acetaminophen Associated With Strong Opioids for Acute Pain in Cancer Patients | NCT04779567 | Acute Pain Cancer Pain | Acetaminophen Placebo | 18 Years - | Pontificia Universidad Catolica de Chile | |
Intravenous Acetaminophen for Craniotomy Patients | NCT01474304 | Craniotomy | Acetaminophen | 18 Years - | Swedish Medical Center | |
Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain | NCT00525967 | Cancer Pain Palliative Care | Methadone plus ... | 18 Years - | Faculdade de Medicina do ABC | |
Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | NCT00324467 | Lymphoma, Non-H... Advanced Stage ... | Cyclophosphamid... Doxorubicin Vincristine Prednisone Ondansetron Dexamethasone Diphenhydramine Acetaminophen Ifosfamide Mesna (IV) Mesna (oral) Carboplatin Etoposide Rituximab Ondansetron Dexamethasone Diphenhydramine Acetaminophen PET Scan | 18 Years - | British Columbia Cancer Agency | |
Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer | NCT01607905 | Solid Tumor | Selinexor Acetaminophen | 18 Years - | Karyopharm Therapeutics Inc | |
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia | NCT01059786 | Hairy Cell Leuk... | Pentostatin Rituximab Bendamustine Acetaminophen Diphenhydramine Epinephrine Antihistamines Corticosteroids Bronchodilators Intravenous (IV... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC) | NCT02839668 | Breast Cancer | Lidocaine Sevoflurane TIVA-TCI Acetaminophen Tramadol Neostigmine Atropine BIS | 18 Years - 80 Years | Iuliu Hatieganu University of Medicine and Pharmacy | |
A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants | NCT03649165 | Neurofibromatos... Healthy Partici... | Treatment A Treatment B Treatment C Treatment D Acetaminophen | 18 Years - 45 Years | AstraZeneca | |
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00003346 | Melanoma (Skin) | acetaminophen acetylcysteine carmustine | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery | NCT01783236 | Lung Tumor | IV Acetaminophe... Saline Placebo | 18 Years - 99 Years | Weill Medical College of Cornell University | |
KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C) | NCT04165096 | Carcinoma, Non-... | Pembrolizumab Boserolimab MK-4830 diphenhydramine acetaminophen MK-0482 | 18 Years - | Merck Sharp & Dohme LLC | |
Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer | NCT00712712 | Metastatic Canc... Pain Unspecified Adu... | Acetaminophen Morphine Sulfat... Questionnaire a... Quality-of-life... Radiofrequency ... | 18 Years - 75 Years | Institut Bergonié | |
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma | NCT04268498 | Multiple Myelom... | Bortezomib Dexamethasone Lenalidomide Acetaminophen Diphenhydramine Montelukast Carfilzomib Daratumumab Autologous Stem... | 18 Years - 75 Years | University of Miami | |
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers | NCT02648490 | Solid Tumour | HLX07 Acetaminophen dexamethasone diphenhydramine 5-HT3 inhibitor | 18 Years - | Henlix, Inc | |
NSAID Use After Robotic Partial Nephrectomy | NCT05842044 | Kidney Cancer Renal Cancer Renal Neoplasm | Ketorolac Acetaminophen Oxycodone Hydromorphone Ibuprofen | 18 Years - 99 Years | University of Miami | |
Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain | NCT00378937 | Pain Unspecified Adu... | acetaminophen codeine phospha... dextropropoxyph... morphine sulfat... oxycodone hydro... management of t... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies | NCT04681105 | Recurrent Acute... Recurrent B Acu... Recurrent Blast... Recurrent Chron... Recurrent Hairy... Recurrent Hemat... Recurrent Hodgk... Recurrent T Acu... Refractory Acut... Refractory B Ac... Refractory Blas... Refractory Chro... Refractory Hair... Refractory Hema... Refractory Hodg... Refractory T Ac... Systemic Mastoc... | Acetaminophen Dexamethasone Diphenhydramine Flotetuzumab Ibuprofen Ranitidine | 12 Years - | City of Hope Medical Center | |
Intravenous Acetaminophen for Craniotomy Patients | NCT01474304 | Craniotomy | Acetaminophen | 18 Years - | Swedish Medical Center | |
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia | NCT03913559 | Acute Lymphobla... | Inotuzumab ozog... Methotrexate Hydrocortisone Cytarabine Diphenhydramine Acetaminophen Methylprednisol... | - 21 Years | St. Jude Children's Research Hospital | |
Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery | NCT01783236 | Lung Tumor | IV Acetaminophe... Saline Placebo | 18 Years - 99 Years | Weill Medical College of Cornell University | |
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma | NCT05896228 | Refractory Mult... Relapsed Multip... | Iberdomide Carfilzomib Daratumumab Dexamethasone Acetaminophen Diphenhydramine Montelukast | 18 Years - 75 Years | University of Miami | |
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery | NCT04176419 | Postoperative P... Opioid Consumpt... | Ketamine Placebo Ketamin... Lidocaine Placebo Lidocai... Acetaminophen Placebo Acetami... Gabapentin Placebo Gabapen... Celecoxib Placebo Celecox... | 18 Years - | Case Comprehensive Cancer Center | |
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy | NCT05597878 | Pain Management Opioid Use Prostate Cancer | Oxycodone Acetaminophen Ketamine Ketorolac Acetaminophen | 40 Years - 75 Years | Wake Forest University Health Sciences | |
Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia | NCT03805932 | Hairy Cell Leuk... | Moxetumomab Pas... Rituximab Ruxience Dexamethasone Acetaminophen Diphenhydramine Famotidine Aspirin | 18 Years - | National Institutes of Health Clinical Center (CC) | |
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma | NCT06356571 | Plasma Cell Mye... | Isatuximab SC-O... Montelukast Dexamethasone Acetaminophen Diphenhydramine Methylprednisol... Carfilzomib | 18 Years - | Sanofi | |
An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients | NCT00576173 | Pain | tramadol hydroc... | 18 Years - | Johnson & Johnson Taiwan Ltd | |
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma | NCT05896228 | Refractory Mult... Relapsed Multip... | Iberdomide Carfilzomib Daratumumab Dexamethasone Acetaminophen Diphenhydramine Montelukast | 18 Years - 75 Years | University of Miami | |
Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma | NCT04840615 | Mesothelioma | LMB-100 ipilimumab Diphenhydramine Famotidine Acetaminophen Dexamethasone Biopsy FDG-PET CT CAP MRI ECG Echocardiogram | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery | NCT03084536 | Breast Cancer Breast Cancer F... Cancer of Breas... | Bupivacaine Gabapentin Celecoxib Acetaminophen Midazolam Fentanyl | 18 Years - | Washington University School of Medicine | |
The TMS Treatment for Postoperative Headache in GH Tumor | NCT04529356 | Headache Pituitary Tumor Acromegaly | Transcranial ma... Acetaminophen | 18 Years - 60 Years | Huashan Hospital | |
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia | NCT01059786 | Hairy Cell Leuk... | Pentostatin Rituximab Bendamustine Acetaminophen Diphenhydramine Epinephrine Antihistamines Corticosteroids Bronchodilators Intravenous (IV... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia | NCT03913559 | Acute Lymphobla... | Inotuzumab ozog... Methotrexate Hydrocortisone Cytarabine Diphenhydramine Acetaminophen Methylprednisol... | - 21 Years | St. Jude Children's Research Hospital | |
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG | NCT00899847 | Transplantation... Transplantation... Multiple Myelom... Blood and Marro... | Autologous peri... Allogeneic peri... Filgrastim Cyclophosphamid... Melphalan Cyclosporine Total lymphoid ... Rabbit anti-thy... Mycophenolate M... Solumedrol Diphenhydramine Acetaminophen Hydrocortisone | 18 Years - 75 Years | Stanford University | |
Allogeneic Transplantation From Related Haploidentical Donors | NCT00185692 | Blood Cancer Leukemia Graft Versus Ho... Malignancy CLL NHL Hodgkin's Disea... MDS | non-myeloablati... Anti-Thymocyte ... Cyclosporine Mycophenolate M... G-CSF Solumedrol Acetaminophen Diphenydramine Hydrocortisone | 12 Months - | Stanford University | |
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood | NCT00923910 | Leukemia, Acute... Leukemia, Acute... Leukemia, Chron... Myelodysplastic... Non-Hodgkin's L... | WT1 Peptide-Pul... Donor Lymphocyt... IL-4 KLH WT1 Peptides Endotoxin Diphenhydramine Acetaminophen | 1 Year - 74 Years | National Institutes of Health Clinical Center (CC) | |
Usefulness of Acetaminophen Associated With Strong Opioids for Acute Pain in Cancer Patients | NCT04779567 | Acute Pain Cancer Pain | Acetaminophen Placebo | 18 Years - | Pontificia Universidad Catolica de Chile | |
KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C) | NCT04165096 | Carcinoma, Non-... | Pembrolizumab Boserolimab MK-4830 diphenhydramine acetaminophen MK-0482 | 18 Years - | Merck Sharp & Dohme LLC | |
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD | NCT00186628 | Leukemia, Mast-... Mantle-cell Lym... | Total lymphoid ... Rituximab Anti-thymoglobu... Cyclosporine Mycophenylate m... Filgrastim Granisetron Solumedrol Acetaminophen Diphenhydramine Hydrocortisone | 18 Years - 76 Years | Stanford University | |
Intravenous Acetaminophen for Craniotomy Patients | NCT01474304 | Craniotomy | Acetaminophen | 18 Years - | Swedish Medical Center | |
Spinal Versus Epidural Analgesia in Laparotomic Liver Surgery | NCT02647047 | Secondary Malig... Liver Diseases Liver Neoplasms | Spinal analgesi... Epidural analge... Transversus Abd... Surgical wound ... Acetaminophen Ketorolac Ropivacaine Sufentanil Ropivacaine Ropivacaine | 18 Years - | Ospedale San Raffaele | |
Acetaminophen for Cancer Pain | NCT00152854 | Cancer Pain | Acetaminophen acetaminophen placebo, sugar ... | 18 Years - | University Health Network, Toronto | |
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) | NCT03258593 | Urinary Bladder... | Durvalumab Vicineum Acetaminophen Antihistamine Bladder Biopsy TURBT Cystoscopy Urine cytology Electrocardiogr... CT MRI | 18 Years - | National Institutes of Health Clinical Center (CC) | |
A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma | NCT01998971 | Multiple Myelom... | Daratumumab Velcade Pomalidomide Dexamethasone Melphalan Prednisone Thalidomide Diphenhydramine Acetaminophen Carfilzomib Lenalidomide Montelukast | 18 Years - | Janssen Research & Development, LLC | |
Usefulness of Acetaminophen Associated With Strong Opioids for Acute Pain in Cancer Patients | NCT04779567 | Acute Pain Cancer Pain | Acetaminophen Placebo | 18 Years - | Pontificia Universidad Catolica de Chile | |
NSAID Use After Robotic Partial Nephrectomy | NCT05842044 | Kidney Cancer Renal Cancer Renal Neoplasm | Ketorolac Acetaminophen Oxycodone Hydromorphone Ibuprofen | 18 Years - 99 Years | University of Miami | |
Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain | NCT00378937 | Pain Unspecified Adu... | acetaminophen codeine phospha... dextropropoxyph... morphine sulfat... oxycodone hydro... management of t... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) | NCT03258593 | Urinary Bladder... | Durvalumab Vicineum Acetaminophen Antihistamine Bladder Biopsy TURBT Cystoscopy Urine cytology Electrocardiogr... CT MRI | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Phase 2 Study of Bexxar in Relapsed/Refractory DLCL | NCT00490009 | Lymphoma | Bexxar Acetaminophen Diphenhydramine Potassium Iodid... | 19 Years - | Stanford University | |
Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain | NCT00525967 | Cancer Pain Palliative Care | Methadone plus ... | 18 Years - | Faculdade de Medicina do ABC | |
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery | NCT03084536 | Breast Cancer Breast Cancer F... Cancer of Breas... | Bupivacaine Gabapentin Celecoxib Acetaminophen Midazolam Fentanyl | 18 Years - | Washington University School of Medicine | |
APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors | NCT02911961 | Acetaminophen E... | Acetaminophen | 21 Years - 80 Years | Denver Health and Hospital Authority | |
A Phase 3 Randomized, Open-label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma | NCT04270409 | Plasma Cell Mye... | Isatuximab SAR6... Lenalidomide Dexamethasone Montelukast or ... Acetaminophen Diphenhydramine... Methylprednisol... | 18 Years - | Sanofi | |
Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009) | NCT03554005 | Neoplasms | PEG Interferon ... Acetaminophen | 18 Years - 70 Years | Merck Sharp & Dohme LLC | |
The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC) | NCT02839668 | Breast Cancer | Lidocaine Sevoflurane TIVA-TCI Acetaminophen Tramadol Neostigmine Atropine BIS | 18 Years - 80 Years | Iuliu Hatieganu University of Medicine and Pharmacy | |
Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT | NCT00482053 | Lymphoma, B-cel... Lymphoma, Non-H... Diffuse Large B... Malignant Lymph... | Autologous hema... Allogeneic hema... Total lymphoid ... Rituximab Carmustine Etoposide Filgrastim Anti-thymocyte ... Cyclosporine Mycophenolate m... Cyclophosphamid... Acetaminophen Diphenhydramine Hydrocortisone Methylprednisol... | 18 Years - 70 Years | Stanford University | |
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma | NCT04268498 | Multiple Myelom... | Bortezomib Dexamethasone Lenalidomide Acetaminophen Diphenhydramine Montelukast Carfilzomib Daratumumab Autologous Stem... | 18 Years - 75 Years | University of Miami | |
Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | NCT00324467 | Lymphoma, Non-H... Advanced Stage ... | Cyclophosphamid... Doxorubicin Vincristine Prednisone Ondansetron Dexamethasone Diphenhydramine Acetaminophen Ifosfamide Mesna (IV) Mesna (oral) Carboplatin Etoposide Rituximab Ondansetron Dexamethasone Diphenhydramine Acetaminophen PET Scan | 18 Years - | British Columbia Cancer Agency | |
Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain | NCT00525967 | Cancer Pain Palliative Care | Methadone plus ... | 18 Years - | Faculdade de Medicina do ABC |